Cargando…
Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term
BACKGROUND: To present a comprehensive approach for the management of patients with neovascular glaucoma (NVG) aiming to preserve visual function and complement pan-retinal photocoagulation (PRP) by anti-vascular endothelial growth factor (anti-VEGF) treatment and anti-glaucoma surgery. METHODS: Thi...
Autores principales: | Sun, Yaoyao, Liang, Yong, Zhou, Peng, Wu, Huijuan, Hou, Xianru, Ren, Zeqin, Li, Xiaoxin, Zhao, Mingwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006321/ https://www.ncbi.nlm.nih.gov/pubmed/27576739 http://dx.doi.org/10.1186/s12886-016-0327-9 |
Ejemplares similares
-
The Optimization of an Anti-VEGF Therapeutic Regimen for Neovascular Glaucoma
por: Bai, Ling, et al.
Publicado: (2022) -
The role of Anti-VEGF agents in treatment of neovascular glaucoma
por: Palfi (Salavat), Mădălina-Casiana, et al.
Publicado: (2022) -
Short-Term Outcomes of Trabeculectomy With or Without Anti-VEGF in Patients With Neovascular Glaucoma: A Systematic Review and Meta-Analysis
por: Zhou, Xi, et al.
Publicado: (2023) -
Is Asthma Related to Choroidal Neovascularization?
por: Sun, Yaoyao, et al.
Publicado: (2012) -
Outcomes of vitrectomy, complete pan-retinal photocoagulation, and endoscopic cyclophotocoagulation surgery after anti-VEGF treatment in neovascular glaucoma
por: Li, Jinglan, et al.
Publicado: (2023)